Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Relationship of radiometabolic biomarkers to KRAS mutation status and ALK rearrangements in cases of lung adenocarcinoma.

Aras G, Kanmaz ZD, Tuncay E, Çetinkaya E, Yentürk E, Kocatürk C, Öz B, Çermik TF, Purisa S.

Tumori. 2019 Dec;105(6):501-508. doi: 10.1177/0300891620902334.

PMID:
31910789
2.

Relation of Warrick Score and Polysomnographic Parameters in Patients with Interstitial Lung Disease.

Sarac S, Kavas M, Sahin M, Aras G, Afsar GC, Tezel YB.

Med Sci Monit. 2019 Mar 21;25:2087-2095. doi: 10.12659/MSM.914905.

3.

Relationship of Radiometabolic Biomarkers to KRAS Mutation Status and ALK Rearrangements in Cases of Lung Adenocarcinoma.

Aras G, Kanmaz ZD, Tuncay E, Çetinkaya E, Yentürk E, Kocatürk C, Öz B, Çermik TF, Purisa S.

Tumori. 2017 Jan 1:tj5000695. doi: 10.5301/tj.5000695. [Epub ahead of print]

PMID:
29781772
4.

To what extent and why are COPD and Willis-Ekbom disease associated?

Mandal T, Aydın Ş, Kanmaz D, Karasulu AL, Aras G, Tuncay E.

Sleep Breath. 2016 Sep;20(3):1021-7. doi: 10.1007/s11325-016-1359-3. Epub 2016 May 30.

PMID:
27240804
5.

Contribution of ¹⁸Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma.

Kanmaz ZD, Aras G, Tuncay E, Bahadır A, Kocatürk C, Yaşar ZA, Öz B, Özkurt CÜ, Gündoğan C, Çermik TF.

Cancer Biomark. 2016;16(3):489-98. doi: 10.3233/CBM-160588.

PMID:
27062706
6.

Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.

Demir Ö, Köse N, Özkan E, Ünlütürk U, Aras G, Erdoğan MF.

Nucl Med Commun. 2016 Jul;37(7):715-20. doi: 10.1097/MNM.0000000000000495.

PMID:
26963467
7.

The role of 18F-NaF PET/CT in metastatic bone disease.

Araz M, Aras G, Küçük ÖN.

J Bone Oncol. 2015 Sep 16;4(3):92-7. doi: 10.1016/j.jbo.2015.08.002. eCollection 2015 Sep.

8.

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.

Lebwohl M, Strober B, Menter A, Gordon K, Weglowska J, Puig L, Papp K, Spelman L, Toth D, Kerdel F, Armstrong AW, Stingl G, Kimball AB, Bachelez H, Wu JJ, Crowley J, Langley RG, Blicharski T, Paul C, Lacour JP, Tyring S, Kircik L, Chimenti S, Callis Duffin K, Bagel J, Koo J, Aras G, Li J, Song W, Milmont CE, Shi Y, Erondu N, Klekotka P, Kotzin B, Nirula A.

N Engl J Med. 2015 Oct;373(14):1318-28. doi: 10.1056/NEJMoa1503824.

9.

Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment.

Soydal C, Araz M, Ozkan E, Arslantaş E, Kucuk ON, Aras G.

Nucl Med Commun. 2015 Feb;36(2):109-13. doi: 10.1097/MNM.0000000000000230.

PMID:
25321158
10.

OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results.

Kimball AB, Rothman KJ, Kricorian G, Pariser D, Yamauchi PS, Menter A, Teller CF, Aras G, Accortt NA, Hooper M, Rice KC, Gelfand JM.

J Am Acad Dermatol. 2015 Jan;72(1):115-22. doi: 10.1016/j.jaad.2014.08.050. Epub 2014 Sep 26.

11.

Translation strategy for the qualification of drug-induced vascular injury biomarkers.

Bendjama K, Guionaud S, Aras G, Arber N, Badimon L, Bamberger U, Bratfalean D, Brott D, David M, Doessegger L, Firat H, Gallas JF, Gautier JC, Hoffmann P, Kraus S, Padro T, Saadoun D, Szczesny P, Thomann P, Vilahur G, Lawton M, Cacoub P.

Toxicol Pathol. 2014 Jun;42(4):658-71. doi: 10.1177/0192623314527644. Epub 2014 Apr 24.

PMID:
24771082
12.

The assessment of high sensitivity C-reactive protein as a systemic marker in moderate asthma patients and changing levels by inhaled corticosteroids.

Kadakal F, Aras G, Kanmaz D, Purisa S, Uzumcu M, Iatk E, Bratfalean D.

J Pak Med Assoc. 2013 Jul;63(7):893-8.

13.

Immunohistochemical expression of telomerase in patients with non-small cell lung cancer: prediction of metastasis and prognostic significance.

Aras G, Kanmaz D, Urer N, Purisa S, Kadakal F, Yentürk E, Tuncay E.

Anticancer Res. 2013 Jun;33(6):2643-50.

PMID:
23749922
15.

Evaluation of the response to selective internal radiation therapy in patients with hepatocellular cancer according to pretreatment (99m)Tc-MAA uptake.

Kucuk ON, Soydal C, Araz M, Ozkan E, Aras G.

Clin Nucl Med. 2013 Apr;38(4):252-5. doi: 10.1097/RLU.0b013e31828162e8.

PMID:
23429390
16.

OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis.

Kimball AB, Pariser D, Yamauchi PS, Menter A, Teller CF, Shi Y, Yong M, Creamer K, Hooper M, Aras G, Kricorian G, Gelfand JM.

J Am Acad Dermatol. 2013 May;68(5):756-64. doi: 10.1016/j.jaad.2012.10.055. Epub 2013 Jan 26.

17.

Gastroesophageal reflux disease in our asthma patients: the presence of dysphagia can influence pulmonary function.

Aras G, Kanmaz D, Kadakal F, Purisa S, Sonmez K, Tuncay E, Ozdemir A.

Multidiscip Respir Med. 2012 Dec 17;7(1):53. doi: 10.1186/2049-6958-7-53.

19.
20.

Unexpected ¹⁸F-FDG uptake in an ocular prosthesis.

Ozkan E, Araz M, Soydal C, Aras G.

Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1517-8. doi: 10.1007/s00259-012-2167-z. Epub 2012 Jun 16. No abstract available.

PMID:
22707182

Supplemental Content

Loading ...
Support Center